The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations.

Background: The hepatitis C virus (HCV) affects approximately 214,000 Canadians. While the availability of safe, effective direct-acting antivirals (DAA) has led to decreased rates of chronic HCV infection and increased treatment uptake, major challenges to achieving HCV elimination remain. This rep...

Descripción completa

Detalles Bibliográficos

Publicado en:	Canadian Liver Journal Vol. 8; no. 4; pp. 540 - 554
Autores principales:	Elakpa, Daniel N, Lawton, David, Tooley, Trinity H, van Rooyen, Kerryn, Bruneau, Julie, Cooper, Curtis, Dickie, Melisa, Feld, Jordan J, Janjua, Naveed Z, King, Alexandra, Kronfli, Nadine, Presseau, Justin, Wilson, Joyce, Vachon, Marie-Louise, Fontaine, Guillaume, on Hepatitis C, on behalf of the Canadian Network
Formato:	Journal Article
Publicado:	University of Toronto Press Nov2025
Acceso en línea:	Ver este registro en EBSCOhost